国家新技术推广培训课程的肿瘤Markers-Shenzhen站和201
1月26日2019年的一个下午由中国抗癌协会肿瘤标志物专业委员会深圳推广公司由中国抗癌协会肿瘤标志物专业委员会北京大学深圳医院国家癌症临床研究中心深圳分中心主办的“全国新技术推广培训课程的肿瘤Markers-Shenzhen站”(2019年第一站)在会议室成功举行1楼的科研大楼、北京大学深圳医院深圳。这次培训的主题是新的肿瘤标记物的临床应用和超过150名临床医生、科研人员和学生参加。
Conference site
Professor Wang Shubin's speech
Professor Wang Dong's speech
Professor Wang Dong and Professor Zhang Hong jointly launched the 2019 World Cancer Marker Committee Cancer Day
"TBM Walks with You on the Road to Anti-Cancer Public Welfare Science Popularization Activities"
Professor Wang Dong and Professor Cui Yongping introduce training experts
Report by Professor Tang Hua Deputy Dean of School of Basic Medicine Tianjin Medical University --Non-coding RNA and tumors
Report by Professor Lou Jiatao Director of the Laboratory of Shanghai Chest Hospital--Prospects for the laboratory differential diagnosis of benign and malignant pulmonary nodules
Jilin Provincial Tumor Hospital Professor Li Hui from the Department of Immunology-Clinical Application and Translational Research of CTC
Report by Professor Zhang Hao of Jinan University-Translational Research of Exosomal Liquid Biopsy and Immunotherapy
Third Military Medical University Professor Li Xiaowu of the First Affiliated Hospital and Professor Wang Xiaomei of the Department of Medicine of Shenzhen University co-hosted the second half of the training
Professor Nie Yongzhan from the Air Force Military Medical University-Intestinal Microecology and Tumor Immunity
Shenzhen Advanced Branch of Chinese Academy of Sciences Report by Professor Wan Xiaochun Deputy Director of the Institute of Medicine and Medicine of the Academy of Medical Sciences--
Research and development of a new tumor detection marker
Report by Dr. Wang Linlin an application expert in the field of oncology from Shenzhen MGI Technology Co. Ltd.--
MGI Application of sequencing platform in the field of tumor
Report by Dr. Fang Liang from the Department of Biology Southern University of Science and Technology--
Application of single-cell sequencing in the field of tumor heterogeneity and immune research
Photo of experts
This Shenzhen station training is the first station of the ?National Promotion and Training of New Tumor Marker Technologies? 在2019年。它已经收到深圳分公司的大力支持国家癌症研究中心的北京大学深圳医院。培训内容是接近于临床实践。参与者的一致赞扬。
2019年中国抗癌协会肿瘤标志物专业委员会将配合省市肿瘤标志物专业委员会组织30“肿瘤标记物”在北京、上海、甘肃、辽宁、吉林、福建、陕西、湖南、黑龙江等地。国家新技术的推广和培训”和“2019年中国肿瘤标记学术会议和13肿瘤标记青年科学家论坛”将在武汉湖北。欢迎专家和教授和相关领域的公司肿瘤标志物参与深度积极促进医学研究和企业之间的合作与交流!